FDA recall, , Moderate risk
LifeServe Blood Center Apheresis Red Blood Cells, Leukocytes Reduced
Apheresis Red Blood Cells, Leukocytes Reduced, had questionable weights and were distributed without quality control being performed.
LifeServe Blood Center began this recall on Sep 15, 2025. FDA posted it on Nov 16, 2026, the day the recall ended.
What happened
LifeServe Blood Center, of Johnston, Iowa, is recalling its Apheresis Red Blood Cells, Leukocytes Reduced. The agency's notice says the product had questionable weights and that quality control was not performed before it was distributed.
The company started the recall on its own on September 15, 2025. Customers were told by telephone. The FDA added the recall to its Enforcement Report and classified it on November 16, 2026.
What to do
Biologics such as blood, tissue and vaccines are usually given by hospitals and clinics. If you had a transfusion, transplant, infusion or vaccine, ask the place that treated you whether this product was used. If they contact you, follow their advice.
What was recalled
Hospitals, clinics and blood banks match these details against their records.
Apheresis Red Blood Cells, Leukocytes Reduced
- Unit number
- W037925198361
Recall details
- Posted by FDA
- Recall began
- Status
- Ended Nov 16, 2026
- Weekly archive
- Listed the week of Nov 16, 2026
- Distributed to
- Recalled by
- LifeServe Blood CenterJohnston, Iowa
- Risk
Moderate risk
Its use may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100032
- Recall number
- B-0057-2027
- Recall type
- Started by the company
- How the company first told customers
- Phone
All recalls from LifeServe Blood Center
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
LifeServe Blood Center began the recall
FDA posted the recall to its Enforcement Report, rated it Class II (moderate risk) and closed it
Added to Recall Canary
